|
2023
|
Invention
|
1,4-substituted piperidine derivatives. Described herein are 1,4-substituted piperidine compounds... |
|
|
Invention
|
Mutant fgf-21 peptide pegylated conjugates and uses thereof.
The present invention relates to a ... |
|
2022
|
Invention
|
Methods of treatment using mutant fgf-21 peptide conjugates. Therapeutic regimens and uses of mut... |
|
2021
|
Invention
|
Spiropiperidine derivatives. Described herein are spiropiperidine compounds according to Formula ... |
|
|
Invention
|
Substituted 4-benzyl and 4-benzoyl piperidine derivates. Described herein are 1,4-substituted pip... |
|
|
Invention
|
Methods for promoting weight loss.
Therapeutic regimens and uses of mutant Fibroblast Growth Fac... |
|
|
Invention
|
Methods for promoting weight loss. Therapeutic regimens and uses of mutant Fibroblast Growth Fact... |
|
2020
|
Invention
|
Method of treating of fibroblast growth factor 21 (fgf-21) deficiency.
The present invention rel... |
|
2018
|
Invention
|
Mutant fgf-21 peptide pegylated conjugates and uses thereof. The present invention relates to a m... |
|
|
Invention
|
Mutant fgf-21 peptide conjugates and uses thereof. The present invention relates to a mutan... |
|
|
Invention
|
Mutant fgf-21 peptide conjugates and uses thereof. The present invention relates to a mutant Fibr... |
|
2016
|
Invention
|
Substituted 4-benzyl and 4-benzoyl piperidine derivatives. Described herein are 1,4-substituted p... |
|
2015
|
Invention
|
Method of treating fibroblast growth factor 21 (fgf-21) deficiency. The present invention relates... |
|
2011
|
Invention
|
Remodeling and glycopegylation of fibroblast growth factor (fgf). The present invention relates t... |
|
2005
|
Invention
|
Remodeling and glycopegylation of fibroblast growth factor (fgf).
The present invention relates ... |
